4005:TSESumitomo Chemical Co., Ltd. Analysis

National Medical Care Company trades at SAR 98.75, comfortably above its 30‑day support of SAR 94.90 but well below the 20‑day (SAR 109.33), 50‑day (SAR 122.62) and 200‑day (SAR 149.18) moving averages, signaling a strong bearish bias. The RSI of 28 and a bearish MACD histogram suggest the stock is oversold, offering a potential short‑term bounce. Volatility is elevated at 47 % over the past month, while the beta of 0.04 indicates minimal correlation with the broader market, meaning price swings are driven more by company‑specific factors than market moves. Valuation metrics are attractive: a trailing PE of 15.5 is well under the industry average of 27.2, and the dividend yield of 3 % with a modest 31 % payout ratio adds income appeal. However, operating cash flow (‑SAR 31.9 M) and free cash flow (‑SAR 306.4 M) are deeply negative, and debt‑to‑equity sits at 27.9 %, raising concerns about cash‑generation sustainability. Analysts (5) rate the stock as a "buy" with a mean target of SAR 175.8, implying a upside of roughly 78 % from current levels, while the Fear & Greed Index at 89 (Extreme Greed) reflects strong market optimism.
Given the blend of undervalued fundamentals, attractive yield, and significant upside potential, the stock may merit a cautious accumulation stance, but investors should monitor liquidity constraints (average daily volume ~274k vs today’s 142 trades) and the company’s ability to fund its dividend amid cash‑flow deficits.